Go Back
This abstract was viewed 137 times

Original research article


One Year Primary Patency of Infrapopliteal Angioplasty Using Drug- Eluting Balloons: Single Center Experience at King Hussein Medical Center

Sizeph Edward HaddadJan Mohammad ShishaniIzzeddin QtaishMohammad Abdelmajeed RawashdehBelal Saleh Qtaishat
Departments of Interventional Radiology and Anasthesiology, King Hussein Medical CenterDepartment of Vascular Surgery, Vascular Surgery Unit, King Hussein Medical Center, Amman, Jordan
Date of Submission: 24-Apr-2017, Date of Acceptance: 24-Jun-2017, Date of Web Publication: 03-Aug-2017.
Corresponding Author:
Corresponding Author

Sizeph Edward Haddad

E-mail: sizephed@yahoo.com

Corresponding Author:
Corresponding Author

Sizeph Edward Haddad

E-mail: sizephed@yahoo.com

DOI: 10.4103/jcis.JCIS_34_17 Facebook Twitter Google Linkedin

ABSTRACT



Objective: Conventional percutaneous transluminal angioplasty (PTA) for long lesions in the below-the-knee (BTK) arteries in patients presenting with critical limb ischemia (CLI) has high restenosis rates at 1 year. Our goal is to evaluate whether paclitaxel drug-eluting balloons (DEB) have higher 1 year primary patency rates compared to conventional PTA.
Methods: This is a single‑center, prospective, randomized trial that was conducted from June 2013 to December 2015. The aim of the study was to compare 1 year primary patency rates of DEB and PTA in BTK arteries in CLI patients. Inclusion criteria were patients presenting with CLI (Rutherford class 4 or greater), stenosis or occlusion ≥30 mm of at least one tibial artery, and agreement to 12-month evaluation. Exclusion criteria were life expectancy <1 year, allergy to paclitaxel, and contraindication to combined antiplatelet treatment. Follow-up was performed by clinical assessment, ankle brachial pressure index, Doppler ultrasound imaging, and conventional angiogram if indicated. Primary end point was 1 year primary patency, and secondary end points were target lesion revascularization (TLR) and major amputation. Statistical analysis was performed using Fischer’s exact test.
Results: Ninety-three patients with 106 lesions in the BTK arteries were enrolled in this study. One year primary patency was achieved in 26 (65%) and seven (17%) in the DEB and PTA groups (P = 0.006), respectively. TLR was performed in nine lesions (23%) and 29 lesions (71%) in DEB and PTA groups (P = 0.009), respectively. Major amputations occurred in one limb (2%) and two limbs (4%) in DEB and PTA groups (P = 0.6), respectively.
Conclusion: Paclitaxel DEB has significantly higher 1 year primary patency rate associated with significantly less TLR than conventional PTA, following endovascular recanalization of BTK arteries in patients presenting with CLI.
Keywords: Balloon Angioplasty, Critical Limb Ischemia, Peripheral Vascular Disease

Cited in 1 Document

  1. Yang Zhou, Shaomang Lin, Zhihui Zhang, Jianbin Xiao, Wenjia Ai, Junwei Wang, Yangyong Li and Qiang Li (2019) A network meta-analysis of randomized controlled trials comparing treatment modalities for infrapopliteal lesions in critical limb ischemia. Annals of Vascular Surgery :. doi: 10.1016/j.avsg.2019.02.021

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.